Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics in Acute Burn Injury
NCT06221761Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Mar 2024
- Primary completion
- Mar 2025
01
Overview
Randomised trial in Burn wound infection (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Negative rate of bacterial culture at 72 hours. Planned start Mar 2024; status: not yet recruiting.
02
Conditions
Burn wound infection
Beyond the preview
Go deeper on NCT06221761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06221761.